HGF and Ewing sarcoma: In a model of Ewing sarcoma, which is characterized by the aberrant expression of hepatocyte growth factor (HGF), AMG102, an HGF receptor neutralizing antibody, improved the antitumor activity of anti-GD2 CAR T cells by increasing CAR T cell trafficking into the tumor mass [196].